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 Abstract 
Moazzami, A.A. 2006. Sesame Seed Lignans - Diversity, Human Metabolism and 
Bioactivity. Doctor’s dissertation. 
ISSN 1652-6880, ISBN 91-576-7147-8 
 
Sesame seed has been an important oilseed since ancient times. It contains 25% protein and 
50% oil. Sesame seed possesses many health promoting effects, some of which have been 
attributed to a group of compounds called lignans (sesamin, sesamolin, sesaminol and 
sesamolinol). Sesame seed contains lignan aglycones in oil and lignan glucosides. Sesamin, 
the major sesame oil lignan, is known to reduce plasma cholesterol and to increase plasma 
γ-tocopherol in humans. 
This thesis aimed at investigating the content of lignan and lignan glucosides in sesame 
seeds, human metabolism of sesamin and the effect of possible interaction between sesamin 
and phytosterols on the bioactivity of sesamin. To these purposes, two new lignan 
glucosides, sesaminol diglucoside and sesamolinol diglucoside, were isolated from sesame 
seeds and characterized by LC-MS and NMR. A method for the analysis of sesame lignan 
glucosides was developed based on extraction of defatted sesame flour with 85% and 70% 
ethanol and using naringenin as internal standard and a reversed phase HPLC-DAD. A 
quantitative NMR technique was also developed to analyze the urinary metabolite of 
sesamin in humans based on using methylenedioxyphenyl signal (δ 5.91) in 
1H-NMR 
spectra of deconjugated urine extracts to measure the metabolite(s) content.  
A diversity of sesame seed oil and products were analyzed for their content of lignans and 
lignan glucosides. It was shown that sesame seeds contain almost 0.6% of lignans and 32% 
of lignans are in glucosylated form of sesaminol and sesamolinol. 
In a human study, volunteers (n=6) consumed a single dose of muffins backed with sesame 
oil containing sesamin and sesamolin. It was shown that almost 30% of sesamin ingested is 
excreted in urine in the form of a major catechol metabolite. 
In an animal experiment, rats were fed diet containing two concentrations of sesamin and 
phytosterols. It was shown that phytosterols reduce the lipid modulating effects of sesamin 
on γ-tocopherol and dihomo-γ-linolenic acid. 
Overall, the findings from this thesis show that sesame seed is a rich source of lignans and 
that at least 30% of sesamin is absorbed in human, however the form of absorption is to be 
elucidated. Moreover, the biopotency of sesamin was reduced when the concentration of 
phytosterols was increased in the diet possibility because of reduction in the bioavailability 
of sesamin. 
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I.  Moazzami, A.A., Andersson, R.E. & Kamal-Eldin, A. 2006. HPLC 
analysis of sesaminol glucosides in sesame seeds. Journal of 
Agricultural and Food Chemistry 54: 633-638. 
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source of dietary lignans. Journal of American Oil Chemist Society 
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IV.  Moazzami, A.A., Haese, S., Kamal-Eldin, A. 2006. Lignan contents 
in sesame seeds and sesame seed products. Manuscript. 
V.  Moazzami, A.A., Andersson, R.E. & Kamal-Eldin, A. 2006. Human 
metabolism and urinary excretion of sesamin. Submitted 
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2006. Phytosterols inhibit lipid modulating effects of sesamin in rats. 
Manuscript. 
 
Reprints were published by kind permission of the journals concerned. 
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CAR  constitutive androstane receptor 
CHD  coronary heart disease 
DSF  defatted sesame flour 
ER estrogen  receptor 
HDL-C  high density lipoprotein cholesterol 
HepG2  human hepatoma cell line G2 
HPLC-DAD  high performance liquid chromatography diode array detector 
IL-6 interleukin  6 
LC-MS  liquid chromatography mass spectroscopy 
LDL-C  low density lipoprotein cholesterol 
LTB4 leukotriene  BB4
LXR  liver X receptor 
NMR  nuclear magnetic resonance spectroscopy  
PAL  phenylalanine ammonia lysase 
PGD2 prostaglandin D2
PGE2 prostaglandin E2
PGF2α prostaglandin  F2α 
PGH2 prostaglandin H2
PGI2 prostaglandin I2
PGG2 prostaglandin G2
PXR  pregnane X receptor 
RP reversed  phase 
S2G sesaminol  diglucoside 
S3G sesaminol  triglucoside 
TC total  cholesterol 
TLC  thin layer chromatography 
TNF-α  tumor necrosis factor-α 
TxA2 thromboxane A2
 
                      
                     
                         
                               
 
  9 
   10
   11 
Sesame  
Sesame belongs to the genus Sesamum, one of 16 genera in the family 
pedaliaceae. The genus Sesamum comprises about 35 wild species besides the 
only cultivated species, Sesamum indicum. The name sesame comes from the 
Arabic word “simsim”. Linnaeus and Brdigian & Harlan (1986) cited India as the 
origin of sesame, however there is also belief that the actual origin was Africa, 
where many wild species are found (Namiki, 1995). In the tale of Ali Baba and the 
40 thieves, in the 'Thousand and One Nights' the password 'open sesame' may have 
been chosen because the ripe seeds burst from their pods suddenly with a sharp 
'pop' like the springing open of a lock. 
 
Sesame is a broad-leaf summer crop with bell-shaped flowers and opposite leaves. 
It is an annual plant that can reach 1-1.8 m high. The plant prefers fertile, well-
drained, and neutral to slightly alkaline pH. Sesame is cultivated in tropical areas 
and needs growing season of 110-150 frost fee days. The best air temperature is 
30-35°C and the soil temperature should not be lower than 20°C. Flowering starts 
about 40 days after planting the seeds and continues for almost another 40 days. 
The flowers then develop into seed pods (capsules), which contain 70-100 seeds 
each. The color of seeds varies from white to brown, gold, gray, violet and black. 
Seeds are tiny and weigh 2-3.5 g/1000 seeds. Seed yield ranges from 350 to 1700 
kg/ha depending on the varieties used and cultivation techniques. According to 
FAO, the average yield is almost 500 kg/ha. 
 
Sesamum indicum is the major commercial source of sesame seeds and primarily 
grown in India, China, Mexico and Sudan. The production of sesame seed in 2002 
was reported as 2.9 million tons world-wide, which puts sesame as the 8
th oil crop 
(FAOSTAT, www.fao.org). The production of sesame seeds is low in comparison 
with soybean with 180 million ton production. This is mainly because of the 
requirement of manual harvest procedures since the sesame plant should be 
harvested before the seed capsules get open on the field and the seeds are lost. 
Following the discovery of a non-dehiscent (non-shattering) mutant by Langham 
in 1943, plant-breeding efforts began toward developing high-yield shatter-
resistant varieties. Sesame plant with semi-shattering and non-dehiscent, in which 
the capsules hold the seeds when they get dry, provides advantages of mechanized 
harvest over traditional shattering plants. 
 
Sesame seeds contain 25% protein and 50% oil. Sesame protein is slightly low in 
lysine but rich in other amino acids specially methionine, cystine, arginine and 
leucine. Sesame oil contains linoleic acid (37-47%), oleic acid (35-43%), palmitic 
(9-11%) and stearic acid (5-10%) with trace amount of linolenic acid (Kamal-
Eldin et al., 1992a).  Sesame seeds contain a group of compounds, called lignans, 
to which many health promoting effects are attributed. 
 
Sesame seeds are used in the preparation of a number of food products. In the Far 
East, sesame seeds are roasted (180-200°C) and their oil is extracted and sold as 
roasted sesame oil in the market. Crude and refined sesame oils are also available   12
in other parts of the world. Sesame oil is used as a salad or cooking oil, in 
shortenings, margarine and to marinate meat and vegetables. Sesame oil was the 
preferred cooking oil in India till the introduction of groundnut (peanut) oil. 
Refined sesame oil is mainly used in pharmaceutical and cosmetic products. 
Sesame seeds can be made into a paste called tahini and a Middle Eastern and 
Indian confection called halva. In India, parts of the Middle East and Far East 
Asia, popular products are made from sesame mixed with honey or syrup. Sesame 
flavor is also very popular in Korean cuisine. The leaves of the sesame plant are 
also used in Korean cuisine as a type of wrap, eaten with meat and other 
vegetables (a traditional dish). Sesame seeds are also sprinkled onto some sushi 
style foods. East Asian cuisines, like Chinese cuisine use sesame seeds and oil in 
some dishes. Japanese cuisine uses sesame seeds in many ways e.g. to make 
goma-tofu, which is made from sesame paste and starch. Whole seeds are found in 
many salads and baked snacks as well. In tempura restaurants, mixtures of sesame 
and cottonseed oils are used for deep-frying.  
 
Sesame seed lignans: chemistry and biosynthesis 
In 1927, Robinson recognized that a common feature of many natural products is a 
C6C3  unit (i.e. a propylbenzene or phenylpropanoid skeleton). In a review of 
natural resins, Haworth (1936) proposed that the class of compounds derived from 
two C6C3 unites possessing β,β′-linkage (8-8´ bond) should be called lignans (his 
original spelling was lignane but the `e´ was deleted in subsequent publications). 
Sesame seeds contain a diversity of furofuran lignans, which can be divided into 
two types: 
 
Oil-soluble (or oil-dispersed) lignans (Figure 1) 
 Sesamin (1) and sesamolin (2) have been considered the major oil-soluble lignans 
of sesame seeds (Namiki et al., 1995). However, small amounts of sesaminol (3), 
Piperitol (4), sesamolinol (5), pinoresinol (6), (+)-episesaminone (7), 
hydroxymatairesinol (10), allohydroxymatairesinol (11) and larisiresinol (12), 
which possess free phenolic groups and therefore, antioxidant activity have been 
reported in sesame seeds (Fukuda et al., 1985, 1988a; Osawa et al., 1985; 
Marchand et al. 1997; Nagashima & Fukuda, 2004). Moreover, the presence of 
other lignans in the wild species of genus Sesamum like sesangolin (8) in 
Sesamum angolense and Sesamum angustifolium and 2-episesalatin (9) in 
Sesamum alatum has been reported (Jones et al., 1962; Kamal-Eldin & 
Appelqvist, 1994; Kamal-Eldin & Yousif, 1992b). The range and some physical 
and chemical properties of sesame seed lignans are addressed in Table 1.  
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Figure 1. Sesame oil-soluble or oil dispersed lignans. The numbering is used from now on 
to refer to the corresponding lignan when the structure is not provided. 
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Glucosylated lignans (Figure 2)  
These are present in defatted sesame flour (DSF). Because antioxidant activity was 
developed after treatment of DSF with β-glucosidase, the presence of water-
soluble and potentially antioxidant lignans in sesame seeds was investigated. 
Sesaminol triglucoside (13), sesaminol diglucoside (14a), sesaminol 
monoglucoside (15), pinoresinol triglucoside (16), two isomers of pinoresinol 
diglucoside (17a,b), pinoresinol monoglucoside (18), were then isolated and 
characterized (Katsuzaki et al., 1992, 1993, 1994a,b). 
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Figure 2. Lignan glucosides in defatted sesame flour isolated by Katsuzaki et al. (1992, 
1993, 1994a,b). The numbering is used from now on to refer to the corresponding lignan 
glucoside when the structure is not provided.  
  14Table 1. Range, molecular formula, UV absorption (λmax, nm) and extinction coefficient 
(εmax, for 1 cm cell) of major sesame seed lignans and lignan glucosides. 
 
    Range 
mg/100 seed 
  Molecular              
formula  Mwt 
λmax  εmax 
(g
-1L)  (nm) 
  15 
 
a The range was based on the data reported previously by Fukuda et al., 1988a; Beroza & 
Kinman, 1955 and Hemalatha & Ghafoorunissa, 2004. 
b The range was based on the data reported previously by Fukuda et al., 1988a.  
c he range was based on the data reported previously b  Ryu et al., 1998.   T y
d Measured in isooctane (Budowski & Markley, 1951).  
e Measured in chloroform (Osawa et al., 1985; Nagata et al., 1987).
  
f Measured in water (Katsuzaki et al., 1994b).  
g Measured in methanol (Katsuzaki et al., 1994b). 
 
 
Sesamolin (2) and sesamolinol (5) possess an oxygen bridge between their 
benzene and furofuran rings (Namiki, 1995). This feature has not been observed in 
the lignan structure of any other genus than Sesamum. However, sesamin (1) has 
been identified in several species of plants (Parmar et al., 1997). It was also 
identified in stem and root bark of some tree species (Chen et al., 1999; Ju et al., 
2001; Meselhy 2003 and Wang et al., 2003). Some of the sesame seed lignans 
including sesamin, sesamolin, sesamolinol, sesaminol, sesangolin, 2-episesalatin, 
and (+)-episesaminone possess methylenedioxyphenyl group (-O-CH2-O-) in their 
molecular structures, a group that has also been observed in the structure of other 
lignans like dibenzocyclooctadiene lignans (Chang et al., 2005). The protons H-8 
and H-8´, on the bridgehead carbons have cis stereochemical configuration in 
sesame seed lignans, which can possibility be explained by stereoselective 
bimolecular phenoxyl radical coupling in the presence of a dirigent protein during 
the biosynthesis of lignans (Davin et al., 1997).  
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Phenylalanine and tyrosine serve as precursors to an enormous number of plant 
substances including tannins, polymeric lignin and lignans. Phenylalanine can first 
be converted to cinnamic acid by the action of the enzyme phenylalanine ammonia 
lysase (PAL). A series of enzymatic hydroxylation,  methylation and reduction 
leads to coumaric acid, caffeic acid, ferulic acid and eventually E-coniferyl alcohol 
(Figure 3) (Mathews et al., 2000). However, it was claimed that [1-
14C] labeled 
tyrosine was incorporated into sesamin (1) when administered to the cell 
suspension cultures of Sesamum indicum (Jain & Khanna., 1973). It was also 
demonstrated that E-coniferyl alcohol undergoes stereoselective coupling to afford 
(+)-pinoresinol in Sesamum indicum seeds. (+)-Pinoresinol is then metabolized 
further in maturing seeds to afford (+)-piperitol, and (+)-sesamin by introduction 
of methylenedioxyphenyl groups (Kato et al., 1998). One-electron oxidation of the 
monolignol, E-coniferyl alcohol, results in random bimolecular radical coupling 
and the production of a mixture containing (±)-dehydrodiconiferyl alcohols, (±)-
pinoresinol and (±)-guaiacylglycerol 8-O-4´-coniferyl alcohol. However, it was 
shown that in the presence of a 78-kD dirigent protein a stereoselective 
bimolecular coupling results in the production of (+)-pinoresinol (Davin et al., 
1997) and that just (+)-pinoresinol can be further metabolized to (+)-piperitol, (+)-
sesamin and (+)-sesamolin (Kato et al., 1998) (Figure 3). Lignans formation is 
developmentally regulated and depends on the stage of seed maturity (Kato et al., 
1998). The most mature seeds at eight weeks efficiently convert (+)-pinoresinol 
into (+)-piperitol and (+)-sesamin, while younger seeds have higher conversion to 
(+)-sesamolin (Jiao et al., 1998). Later, it was shown that the content of sesaminol 
(3) is increased at the end of seed maturation (Ono et al., 2006) (Figure 3). It was 
suggested that microsomal preparation of sesame seeds catalyzes 
methylenedioxyphenyl formation via an O2/NADPH/chytochrome P-450 
dependent transformation of (+)-pinoresinol into (+)-piperitol (Jiao et al., 1998). 
Possible subsequent metabolic steps of the conversion of (+)-pinoresinol into (+)-
piperitol and (+)-sesamin were suggested by Jiao et al. (1998). Recently, it was 
shown that the synthesis of sesamin from pinoresinol is catalyzed by CYP81Q1 in 
two steps (Figure 3) (Ono et al., 2006). However, the mechanism of oxygen 
insertion between furofuran and benzene rings to form sesamolin and the pathway 
to sesaminol are yet to be elucidated. 
 
Sesamin (1) has been suggested to undergo further metabolism to form (+)-
episesaminone (7), a keto-lignan, which was isolated from commercially available 
unroasted and unbleached sesame seeds as well as freshly harvested seed tissue 
(Marchand et al. 1997). Given that (+)-episesaminone can exist in its lactol form 
under basic condition, only a single oxidation step from (+)-sesamin to (+)-
episesaminone is required (Marchand et al. 1997). 
 
Changes in metabolism occur during germination of sesame seeds (Kuriyama et 
al., 1995 and Ishiyamo et al., 2006). It was shown that in the early stage of 
germination, up to 48 h, sesamin (1) and sesamolin (2) almost disappear and the 
content of sesaminol diglucoside (14b) increases. (+)-Episesaminone tri- and 
diglucosides are also generated during early stages of germination. These lignan 
glucosides existed in germinated sesame seeds for at least seven days after their 
appearance (Kuriyama et al., 1995).   
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Figure 3. Biosynthesis of lignans from phenylalanine or tyrosine. Stereoselective coupling 
of two E-coniferyl alcohol is performed in the presence of a dirigent protein. Pinoresinol 
can be further metabolized to sesamin and sesamolin. The pathway to sesamolin, 
sesamolinol and sesaminol are yet to be elucidated.  
 
Lignan transformation during refining and antioxidative activity  
Roasted sesame oil has been considered as highly resistant to oxidative 
deterioration. It was shown that the rate of absorption of oxygen by sesame oil was 
lower than that for other edible oils and it was more stable under prolonged 
storage regarding both rancidity and free fatty acid content in comparison with 
other oils used in therapeutics (Budowski & Markley, 1951). 
 
Three different types of sesame oil, including crude (virgin), roasted and refined 
sesame oils are produced. Sesame oil from unroasted sesame seeds is extracted 
with an expeller or solvent. This oil can undergo alkaline refining, bleaching with 
acidic clay and deodorization, as done for other vegetable oils, to produce refined 
sesame oil. On the other hand, roasted sesame oil, extracted from roasted sesame 
  17   18
seeds, is only filtered to remove contaminants. Comparison of autoxidation of 
commercial oils at 60°C revealed that soybean, rapeseed, safflower and corn oil 
began to oxidize after 5-20 days incubation, while refined sesame oil was oxidize 
after 35 days. Under this condition, roasted sesame oil was shown to remain 
unaltered even after 50 days (Fukuda et al., 1988b).  
 
Refined sesame oil was reported to contain some amount of sesaminol (6-60 
mg/100g oil) (Fukuda et al., 1986a). During the bleaching, in the presence of 
acidic clay and heat, sesamolin is first decomposed into sesamol and oxonium ion 
by protonolysis and then a new carbon-carbon bond is formed to produce 
sesaminol. Therefore, an intermolecular transformation was suggested for 
conversion sesamolin to sesaminol during bleaching (Fukuda et al., 1986b). 
Epimerization of the sesame oil lignans also happens during bleaching, in which 
episesamin and episesaminol are formed (Fukuda et al., 1986a) (Figure 4). 
 
Even though, the content of γ-tocopherol is reduced during refining of sesame oil, 
the refined oil has a stronger antioxidant activity in comparison with the crude oil. 
The antioxidant activity of sesaminol is roughly equal to those of sesamol and γ-
tocopherol by the thiocyanate method. Moreover, sesamol that is also produced 
from sesamolin during bleaching is nearly removed by subsequent deodorization. 
Therefore, the antioxidant activity of refined sesame oil was mainly attributed to 
sesaminol and residual γ-tocopherol (Fukuda et al., 1986a).  
 
The quality (flavor, color and oxidative stability) of the roasted sesame oil 
depends mainly on the roasting conditions. The degrees of browning and oxidative 
stability of the roasted sesame oil are increased by higher roasting temperature. 
The content of sesamol is not correlated with the increase in roasting temperature, 
even though it was shown that sesamol is also produced from sesamolin during 
roasting by thermal decomposition (Fukuda et al., 1986b). It was shown that 
sesamol, sesamolin, sesamin, γ-tocopherol, browning materials can not 
individually account for the high oxidative stability of roasted sesame oil, and a 
system composed of all these sesame oil components synergistically protect 
roasted sesame oil against oxidative deterioration (Namiki 1995).    
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Figure 4. Transformation of sesame oil lignans during bleaching with acidic clay. 
(1) Bleaching by acidic clay. (2) Hydrolysis or heating. 
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Bioavailability and metabolism of sesame seed lignans 
The term “bioavailability” was initially introduced in the field of pharmacology 
and pharmacokinetics, where it was defined as “the fraction of a given dose that 
reaches the systematic circulation unchanged (Rowland & Tozer, 1995). 
Bioavailability is commonly applied to both rate and extent of drug or dietary 
compounds input into the systematic circulation. Absorption is defined as the 
process by which unchanged drug proceeds from the site of administration to the 
site of measurement within the body, which is the general circulation. For an 
orally administered compound, there are several possible sites of loss before it 
reaches the general circulation. One site is gastrointestinal lumen where 
decomposition may occur. However, if the drug or dietary compound survives the 
destruction in the lumen, then it can be metabolized by enzymes when it passes 
through the membranes of the gastrointestinal tract. Taking one step further, drugs 
or dietary compounds, which are not absorbed through the lymph, pass into the 
portal vein where they are carried to the liver and undergo further metabolism. 
Indeed, loss at any site prior to the site of measurement contributes to a decrease in 
systematic absorption and bioavailability. The gastrointestinal tissues and the liver 
are often sites of elimination and the requirement for dietary compound to pass 
through these tissues, prior to reaching the systematic circulation causes the extent 
of absorption to be dependent on elimination. The loss of a dietary compound for 
the first time during absorption, through sites of elimination such as the 
gastrointestinal membranes and the liver, is known as the first-pass effect 
(Rowland & Tozer, 1995). 
 
In food products, bioaccessibility is defined as the amount of an ingested food 
compound that becomes available for absorption in the gastrointestinal tract. In 
this context, the bioavailability is also dependent on the bioaccessibility of the 
compound. In general, bioaccessibility is an integration of food matrix and all 
luminal events. In order for food components to be absorbed, they must be 
released from the food matrix and be presented to the brush-border of small 
intestine. This depends on the state of food (raw or processed), particle size, 
digestive enzymes, composition of meal and the presence of bile acids and salts. 
For example, it was shown that the bioavailability of enterolignans in human is 
enhanced by milling and crushing of flaxseed (Kuijsten et al., 2005). 
 
Most dietary phenolic compounds are in O-glycoside form and their hydroxyl 
groups, which are relevant for antioxidant activity, are blocked. Glucosidases in 
tissues or from bacteria in the gut remove the conjugated carbohydrate and the 
phenolic compounds are active antioxidants again (Stahl et al., 2002). Xenobiotic 
metabolizing enzymes, such as cytochrome P450 (CYP450), conjugating enzyme 
of phase II biotransformation (e.g. UPD-glucuronosyl transferases or phenol 
sulphotransferases) play a major role in the metabolism of dietary phenolic 
compounds including antioxidants and lignans. Metabolic processes may 
considerably change the function of a particular compound, and metabolism 
generally results in the formation of derivatives that are more suitable for 
excretion than the parent molecules. Moreover, compounds generated by the 
transformations may be more or less bioactive than the parent compounds. Nakano   21 
et al. (2006) suggested that sesamin metabolites generated after incubation with rat 
liver microsomes (Nakai et al., 2003) induce an endothelial nitric oxide-dependent 
vasorelaxation.  
 
Knowledge about the metabolism, and identification of metabolites is thus vital to 
the understanding of the mechanism of bioactivity and ultimately the identification 
of active compounds. It is also important for assessing the risk that might be 
associated with toxic effects of active dietary compounds (Stahl et al., 2002).  
 
A small amount of sesamin (0.1%) was shown to be absorbed through the lymph 
in rats (Hirose et al., 1991; Umeda-Sawada et al., 1999) and sesamin was also 
detected in the plasma of human volunteers after a single dose of sesame seeds 
(Penalvo et al., 2005). The metabolism of sesamin has also been investigated in 
vitro and in vivo (Figure 5). Incubation of sesamin with liver microsomes causes 
the cleavage of methylenedioxyphenyl group in the molecule to form catechol 
derivatives (Nakai et al., 2003). Moreover, it was shown that sesamin can 
undergoes further cleavages in its furofuran ring after 24 hour fermentation with 
human fecal microflora in vitro (Penalvo et al., 2005) or administration to rats 
(Liu et al., 2006).  
 
Mammalian lignans, enterolactone and enterodiol (Figure 5) are the end-products 
of dietary lignan fermentation by mammalian intestinal microflora (Borriello et al., 
1985; Heinonen et al., 2001 and Saarinen et al., 2000). It was shown that the 
consumption of a single dose of sesame seeds by four volunteers increased the 
plasma concentration of enterolactone and enterodiol (Penalvo et al., 2005).   
Coulman  et al. (2005) also showed that the urinary excretion of mammalian 
lignans is increased after four week intervention with sesame bars containing 25 g 
seed. Little is known about the contribution of different sesame seed lignans in the 
production of mammalian lignans. However, it was shown that sesamin, the major 
sesame oil lignan, is converted to enterolactone, enterodiol and three other 
intermediate metabolites after 24 hour fermentation with human microflora in vitro 
(Penalvo et al., 2005). 
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Figure 5. Possible pathway of sesamin metabolism in rats as suggested by Liu et 
al., 2006. M1-4 were produced after incubation of sesamin with rat liver 
microsomes. M1, M4 and M5 were produced after 24 hour fermentation with 
human fecal microflora in vitro (Penalvo et al., 2005) 
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Bioactivity of sesame seed and its lignans 
Sesame seed has been an important oil-seed since ancient times (Namiki, 1995). It 
was claimed in ancient Chinese books that consumption of sesame seeds (Chih-
Ma in Chinese) provides increased energy and prevents aging. Sesame oil (Tila in 
ancient Indian language, Sanskrit) has been used as a domestic Ayurvedic 
medicine (roughly translated to science of life). Recently, scientific studies have 
attributed many of health-promoting effects of sesame seed to its lignans specially 
sesamin, which is the major oil-soluble lignan. 
 
Reduction of cholesterol 
Coronary heart disease (CHD) is the number one cause of morbidity and mortality 
in industrialized western countries. A positive relationship between high blood 
cholesterol concentrations, particularly low-density lipoproteins cholesterol (LDL-
C), and the incidence of atherosclerosis and CHD has been clearly established. 
Lowering blood cholesterol by dietary intervention is one of the first measures in 
prevention of CHD (Assmann et al., 1999). Sesame oil and lignans have been 
investigated for their cholesterol-lowering effect. It was observed that sesame oil 
tended to reduce serum cholesterol levels in rats compared to corn oil in spite of 
the comparable fatty acid composition of the two oils (Koh, 1987). Hirose et al. 
(1991) showed that serum and liver cholesterol were reduced in rats fed diet 
containing 0.5% sesamin. They demonstrated that the hypocholesterolemic 
activity of sesamin can, at least in part, be explained by the inhibition of the 
intestinal absorption of cholesterol as reflected by the significant reduction in 
cholesterol in the thoracic lymph and a significant reduction in the activity of liver 
microsomal 3-hydroxy-3-methylglutaryl coenzyme A reductase, which is a rate 
limiting enzyme in biosynthesis of cholesterol. Consumption of 32 mg sesamin 
capsules for 4 weeks followed by 65 mg sesamin capsules for 4 weeks reduced 
total cholesterol (TC) (9%), LDL-C (16.5%) and apoprotein B (10.5%) in 12 
males with hypercholesterolemia (Hirata et al., 1996). In another study, 21 
hypercholesterolemic subjects consumed 40 g of roasted sesame seeds for 4 
weeks. The results showed that the sesame diet significantly decreased the levels 
of serum TC (6.4%) and LDL-C (9.5%). However, the effect of sesame seeds on 
cholesterol disappeared when patients stopped the consumption of sesame diet 
(Chen et al., 2005). Wu et al. (2006) also observed similar reductions in TC and 
LDL-C in 24 postmenopausal subjects following a 5-week intervention with 50 g 
pulverized roasted sesame seed. High density lipoprotein cholesterol (HDL-C) was 
unchanged in all mentioned human studies after intervention of sesamin or sesame 
seed (Hirata et al., 1996; Chen et al., 2005 and Wu et al., 2006). Since the diet can 
be an effective mean to lower blood levels of total and LDL cholesterol 
(Delahanty et al., 2001 and Sikand et al., 2000), drug therapy may be reserved for 
patients who are at high risk for CHD (Expert Panel on Detection, Evaluation and 
Treatment of High Blood Cholesterol in Adults, 1993). It was shown that sesame 
and its lignans can reduce TC and LDL-C in hypercholesterolemic patients and 
postmenopausal women who have higher prevalence of hypercholesterolemia 
(Chang et al., 2002). 
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Enhancement of vitamin E level 
The tocopherol and tocotrienol vitamers that comprise the vitamin E family are 
considered the most important lipophilic radical-quenching antioxidants in cell 
membranes. While their function is most often associated with the reduction of 
peroxyl radicals, novel vitamer-specific roles for tocopherols in signal 
transduction and in the quenching of other reactive chemical species such as 
nitrogen dioxide and peroxynitrite are now being investigated (Brigelius-Flohe & 
Traber, 1999). While α-tocopherol has attracted a lot of attention, recent studies 
indicate that several of these important roles may be specific to γ-tocopherol. For 
example it was shown that γ-tocopherol and its major metabolite, 2,7,8-trimethyl-
2-(beta-carboxyethyl)-6-hydroxychroman (γ-CEHC), inhibit cyclooxygenase 
activity in stimulated macrophages and epithelial cells and therefore, reduces the 
synthesis of prostaglandin E2 (PGE2) (Jiang et al., 2000, 2001). Moreover, in 
carrageenan-induced inflammation in male wistar rats, administration of γ-
tocopherol (33 mg/kg) can reduce PGE2, Leukotriene B4, and tumor necrosis 
factor-alpha (TNF-α) (Jiang &  Ames, 2003). It was demonstrated that 
administration of sesame oil and it lignans increase blood and tissue 
concentrations of γ-tocopherol without altering those of α-tocopherol in rats 
(Yamashita et al., 1992; Kamal-Eldin, et al., 1995, 2000 and Ikeda et al., 2002). 
The inclusion of unrefined sesame oil in the habitual diet of healthy women over a 
4 week intervention period raised plasma level of γ-tocopherol by 42% without 
altering α-tocopherol (Lemcke-Norojärvi et al., 2001). In another study, plasma γ-
tocopherol increased by 19% in volunteers only after 3 days of intervention with 
muffins containing  sesame seed (equal to a daily dose of 35 mg sesamin and 13 
mg sesamolin) (Cooney et al., 2001).  
 
Sontag  & Parker, (2002) suggested a cytochrome P450 4F2 mediated ω-
hydroxylation pathway for γ-tocopherol catabolism, which was inhibited by 
sesamin. It was also shown that the urinary excretion of γ-tocopherol metabolites 
was significantly lower in volunteers after the consumption of sesame oil muffins 
(Frank et al., 2004a). These data suggest that sesamin can possibly inhibit the 
catabolism of γ-tocopherol, which results in its higher bioavailability observed in 
human and animal studies (Yamashita et al., 1992; Kamal-Eldin, et al., 1995, 
2000; Ikeda et al., 2002; Lemcke-Norojärvi et al., 2001; Cooney et al., 2001 and 
Sontag et al. 2002). Recently, Abe et al. (2005) demonstrated that dietary sesame 
seeds elevate α-tocopherol concentration in rat brain. They showed that the 
concentration of α-tocopherol in the brain of rats (Cerebrum, cerebellum, brain 
stem, and hippocampus) fed 50 mg α-tocopherol/kg with sesame seeds was higher 
than that of the rats fed 500 mg α-tocopherol/kg without sesame seed. These 
results suggest that the dietary sesame seeds are more useful than the intake of an 
excess amount of α-tocopherol, for maintaining a high α-tocopherol concentration 
and inhibiting lipid peroxidation in the various regions of the rat brain (Abe et al., 
2005). 
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Effect on lipid metabolism and inflammatory responses 
Diet containing sesame seeds (200 g/kg) was shown to increase both the hepatic 
mitochondrial and peroxisomal fatty acid oxidation rate in rats. Noticeably, 
peroxisomal activity levels were increased >3 times in rats fed diets containing 
sesame seeds than those fed a control diet without sesame seed. Sesame diet also 
significantly increased the activity of hepatic fatty acid oxidation enzymes 
including acyl-CoA oxidase, carnitine palmitoyltransferase, 3-hydroxyacyl-CoA 
dehydrogenase and 3-ketoacyl-CoA thiolase (Sirato-Yasumoto et al., 2001). In 
contrast, sesame diet lowered the activity of enzymes involving in fatty acid 
synthesis including fatty acid synthase, glucose-6-phosphate dehydrogenase, ATP-
citrate lyase and pyruvate kinase (Sirato-Yasumoto et al., 2001). Similar effects on 
hepatic fatty acid oxidation and synthesis were also observed when rats were fed 
diets containing pure sesamin (1) or episesamin (0.2%) for 15 day suggesting the 
possible involvement of sesame oil lignans in the induction of the observed 
changes in hepatic fatty acid metabolism (Kushiro et al., 2002). Considering lower 
serum triacylglycerol observed in rats fed sesame seed diets, Sirato-Yasumoto et 
al. (2001) suggested that sesame seeds can possibly exert their triglyceride-
lowering-effect through increasing fatty acid oxidation and reducing fatty acid 
biosynthesis in the liver. However, a 5-week intervention with 50 g pulverized 
roasted sesame seed in postmenopausal women (Wu et al., 2006) or a 4-week 
intervention of 40 g roasted sesame seed in hypercholesterolemic patients (Chen et 
al., 2005) did not alter the level of serum triglyceride.   
 
Sesame seed lignans, such as sesamin (1), episesamin, sesamolin (2), sesaminol 
(3) as well as sesamol are known to inhibit the Δ5-desaturase activity, which is an 
enzyme in the biosynthesis of arachidonic acid from dihomo-γ-linolenic acids in 
vitro (Shimizu et al., 1991; Chavali & Forse, 1999) (Figure 6). Moreover, sesamin 
increases dihomo-γ-linolenic acid and the ratio of eicosapentaenoic acid/α-
linolenic acid and decreased the ratio of arachidonic acid/ dihomo-γ-linolenic 
acids in liver lipids of rats fed sesamin (0.5% w/w). Therefore, it has been 
suggested that sesamin inhibits the Δ5-desaturase activity of n-6 fatty acids but not 
that of n-3 fatty acids in vivo (Fujiyama-Fujiwara et al., 1995; Mizukuchi et al., 
2003). 
 
There are conflicting data concerning the arachidonic acid content of the liver 
lipids in rats fed sesamin, which can possibly be originated from different fatty 
acid profiles in the diet (Fujiyama-Fujiwara et al., 1995; Kamal-Eldin et al., 2000; 
Mizukuchi et al., 2003). Wu et al. (2006) showed that consumption of 50 g roasted 
sesame seed for 5 weeks reduced the content of arachidonic acid in the serum 
lipids of postmenopausal women with no effect on dihomo-γ-linolenic acids 
content. Arachidonic acid is the precursor of eicosanoids, which are a class of 
lipids including prostaglandins, thromboxanes and leukotrienes. The release of 
arachidonic acid from membrane phospholipids, which is the first stage in 
biosynthesis of eicosanoids, can occur as a result of tissue-specific stimuli. The 
released arachidonic acid then undergoes oxygenation by cyclooxygenase to yield 
prostaglandin H2 (PGH2), which serves as precursor to other prostaglandins and 
thromboxanes (Mathews et al., 2000). Chavali et al. (1998) showed that the   26
lipopolysaccharide-induced production of PGE2  is lower and that of TNF-α is 
higher in mice fed a diet containing 0.25% sesamin. In addition, they showed that 
sesamol, a sesamolin hydrolysis product, can reduce lipopolysaccharide-induced 
production of PGE2 and interleukin 6 (IL-6) without increasing TNF-α (Chavali et 
al., 1999). Proinflammatory mediators, such as PGE2, can influence the production 
of cytokines which mediate inflammatory responses during inflammation and 
infection (Pruimboom et al., 1994). However, the reduction in PGE2  in mice, 
exerted by sesamin and sesamol, poses different effect on interleukins and TNF-α 
possibly because of different mechanisms. Despite lack of differences in the levels 
of arachidonic acid, the PGE2 levels were reported to be significantly lower in 
mice fed sesamin or sesamol supplemented diets. Therefore, Chavali et al. (1998, 
1999) suggested that sesamin, sesamol or their metabolites decrease the activity of 
cyclooxygenase and the biosynthesis of prostaglandins.   
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Figure 6. Biosynthesis of acachdonic acid and prostaglandins (E2) from linoleic acid. TxA2: 
Thromboxane A2, PG2: Prostaglandin G2,  PH2: Prostaglandin H2, PE2: Prostaglandin E2,  
PGF2α: Prostaglandin PGF2α, PD2: Prostaglandin D2, PI2: Prostaglandin I2.
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Bioactivity through conversion to mammalian lignans 
Consumption of sesame seed was shown to increase plasma and urinary exertion 
of enterolactone and enterodiol (Penalvo et al., 2005; Coulman et al., 2005). 
Epidemiological and laboratory studies have shown that high plasma and urinary 
concentration of enterolactone are inversely correlated with the risk of certain 
chronic disease, such as breast cancer (Adlercreutz et al., 1982; Ingram et al., 
1997 and Pietinen et al., 2001), prostate cancer (McCann et al., 2005 and Hedelin 
et al., 2006) and coronary heart disease (Vanharanta et al., 1999; Vanharanta et 
al., 2003 and Kilkkinen et al., 2006).  
 
Phytoestrogen, including mammalian lignans and isoflavones, are structurally and 
functionally comparable to estradiol-17β and are capable of producing estrogenic 
effect. Mammalian lignans bind to the estrogen receptors (ER) at lower level 
compare to the endogenous estrogen and may exert both estrogenic and 
antiestrogenic effects (Murkies et al., 2005). It was shown that the concentration 
of enterolactone in the prostate fluid is significantly higher than their plasma level 
(Morton et al., 1997). Estradiol-17β stimulates hepatic production of sex hormone-
binding globulin. This protein binds both estrogens and androgens, regulating the 
levels of free hormones in the plasma. It was also shown that intervention with 
sesame seed in postmenopausal women can increase the level of sex hormone-
binding globulin in serum (Wu et al., 2006). However, whether this effect is 
exerted by sesame seed lignans or mammalian lignans produced from sesame seed 
lignans in gut is not clear. Moreover, it was shown than enterolactone upregulate 
LDL receptor activity in human hepatoma cell line (HepG2) (Owen et al., 2004). 
This suggests another possible mechanism for cholesterol lowering effect of 
sesame seed and its lignans. 
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Objectives 
The objectives of this thesis included: 
 
Isolation and characterization of major lignan glucosides in the defatted flour of 
sesame seeds (Papers I, II,).  
 
Method development for the analysis of lignan glucosides in sesame seeds (Paper 
I).  
 
Quantification of lignan glucosides in the defatted sesame flour from a wide 
collection of sesame seeds and products (Papers I, II, , IV). 
 
Quantification of lignans in the oil extracted from a wide collection of sesame 
seeds and products and commercial oils available in the market (Papers III, IV). 
 
Identification of the major sesame lignan metabolite(s) in human urine after 
ingestion of a single dose of sesame oil (Paper V).  
 
Development of NMR method for the quantification of the major sesamin 
metabolite in human urine after ingestion of a single dose of sesame oil (Paper 
V). 
 
Investigation of the interactions between sesamin and phytosterols with regard to 
lipid metabolism using rats as a model (Paper VI).   
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Materials and methods 
Isolation of sesame lignan glucosides from defatted sesame flour 
Sesame seeds (with high concentration of lignans) were grinded and defatted with 
n-hexane to obtain defatted sesame flour (DSF), which was extracted with 80% 
ethanol to obtain a crude extract. This crude extract was then used for the isolation 
of lignan glucosides. 
 
For the isolation of sesaminol triglucoside (13), the crude extract from DSF was 
dissolved in 25% methanol, applied on a Buckner funnel packed with Bondesil-
C18 silica, and eluted with 25, 50, 75 and 100% methanol in series. The 50 and 
75% fractions were pooled, dried and dissolved in chloroform/methanol (1:1, v/v) 
and applied on a silica column and the column was eluted with 
chloroform/methanol (1:1, v/v). Fractions were collected in 10 mL tubes and 
monitored by HPLC-DAD equipped with reversed-phase column to identify those 
tubes containing sesaminol triglucoside (Paper I).  
 
For the isolation of the sesaminol diglucoside (14b), the crude extract was 
dissolved in methanol and used for thin-layer chromatography (TLC). The plates 
were developed using chloroform/methanol (1:1, v/v) and visualized by iodine 
vapour and Rf values for the different spots on the TLC plates were calculated. 
The spot (Rf 0.65-0.72) was scraped, extracted and assigned as a new isomer of 
sesaminol diglucoside by LC-MS and NMR (Paper I). 
 
For the isolation of sesamolinol diglucoside (19), the crude extract from DSF was 
dissolved in chloroform/methanol (4:1, v/v) and applied on silica gel cartridges, 
which were eluted with chloroform/methanol (4:1, v/v). This was performed to 
increase the ratio of sesamolinol diglucoside relative to more polar compounds, 
like sesaminol triglucoside, in the crude extract prior to separation and collection 
of sesamolinol diglucoside by analytical HPLC-DAD equipped with reversed-
phase column (Paper II). 
 
Characterization and identification of molecules 
The structures of the compounds separated by different technique were assigned 
by nuclear magnetic resonance spectroscopy incorporating 
1H-NMR, 
13C-NMR, 
COSY, TOCSY, HMBC, HSQC, ROESY and NOESY, HPLC-DAD and LC-MS 
equipped with electrospray ionization (ESI) and reversed phase column 
chromatography eluted with 10 mM acetic acid (pH 3) and acetonitrile (Papers I, 
II, V). 
 
Seeds, oil and products 
In this thesis, two groups of sesame samples were analyzed for their contents of 
lignans and lignan glucosides.  
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Group 1. Sixty-five different sesame seed samples, bred, grown and harvested in 
Sesaco corporation nurseries in Texas, USA were used. The seeds had white 
(n=47), black (n=11), brown and yellow color (n=7). Seeds from semi-shattering 
(n=7) and non-dehiscent (n=29) plants were harvested when the plants were dry 
and the dehiscent types (shattering) (n=29) were harvested when half of the plants 
were dry. The plants were hand-selected, hand cut, put through a plot thresher and 
carefully cleaned to remove all foreign materials (Papers I, II, III). 
 
Group 2. Eighteen different sesame seeds varying in colour (White, brown, black 
and mixed color) and in the presence (n=14) or absence of hull (n=4) were 
purchased from local market in different countries. Fourteen different products 
containing either sesame oil or sesame seeds including six sesame pastes (Tahini) 
varying in brands were acquired from different countries. Nine different sesame 
oil samples including virgin sesame oil (n=4) and roasted sesame oil (n=5) were 
purchased from local market of different countries (Paper IV). 
 
Quantification of oil-soluble lignans 
Sesame seeds and products were grinded and their oil was extracted using 
hexane/isopropanol (3:1, v/v). The solvent was then evaporated and the oil content 
was determined before it was analyzed for its contents of lignans (vide infra). The 
oil samples were dissolved in n-hexane and analyzed by an HPLC equipped with 
fluorescence detector and normal-phase column. The fluorescence detector was 
operated at an excitation wavelength of 296 nm and an emission wavelength of 
324 nm. The sesamin, sesamolin and γ-tocopherol contents of oil samples were 
then calculated using authentic external standards (Papers III, IV).  
 
Quantification of lignan glucosides 
The defatted flour after oil extraction was dried and used for the analysis of lignan 
glucosides. The defatted flour was first extracted with 85% ethanol containing 
naringenin as internal standard. The extraction was continued overnight with 70% 
ethanol after adjusting the extraction volume with water. This method was shown 
to provide higher recovery in comparison with either 70, 80 or 85% ethanol, 
possibly because of preventing enzymatic degradation or because of better 
extractability of lignan glucosides from matrix, when the extraction is performed 
with different mixtures of ethanol, which possess different polarity (Papers I, II, 
IV). 
 
The quantities of sesaminol tri- and di-glucoside and sesamolinol diglucoside were 
calculated from the peak areas at 290 nm against naringenin as internal standard 
using HPLC-DAD equipped with reversed-phase column. The response factor for 
sesaminol relative to naringenin was established as 0.345 and was assumed to be 
similar for sesamolinol considering the similar extinction coefficients (Osawa et 
al., 1985 and Katsuzaki et al., 1994b) (Papers I, II, IV). 
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Metabolism of sesame seed lignans by humans 
After one week maintaining a diet low in lignans, overnight blank urine was 
collected from volunteers who participated in studies as follows: 
 
In a pilot study, a 30-year-old man took commercial capsules containing sesamin 
(110 mg) and sesamolin (6 mg). The urine was collected for 24 hours and used for 
the isolation of metabolite(s).  
 
In the main study, volunteers (n=6) ate muffins baked with sesame oil containing 
sesamin (180 mg) and sesamolin (71 mg). The treatment urine was then collected 
for four 12-hour-intervals. The samples were at -20°C until the analysis.  
 
The urine samples were deconjugated by β-glucuronidase/sulphatase and extracted 
with chloroform. The chloroform extracts were dried, dissolved in methanol and 
separated by analytical HPLC-DAD equipped with revered-phase column. A peak 
(RT=37.5 min) with characteristic lignan spectra  was collected from the 
chloroform extract of treatment urine using the analytical HPLC. This peak was 
then characterized using NMR and LC-MS (Paper V).  
 
Quantification of major urinary metabolite(s) by 
1H-NMR and HPLC 
The amount of the sesame lignan metabolite in the chloroform extract of 
deconjugated urine from the volunteers was quantified by NMR. Portions of the 
chloroform extract were dried and dissolved in CD3OD and analyzed by 
1H-NMR. 
Signals corresponding to protons of the methylenedioxyphenyl group (MDP) (δ 
5.91) in 
1H-NMR spectra of the treatment urine were used for the quantification of 
the metabolite in the chloroform extracts of urine against authentic sesamin 
solution in CD3OD. Sesamin has two MDP groups in its molecule. Therefore, it 
was assumed that sesamin has twice the NMR response in similar molar solution 
as its catechol metabolites. The methyl group from residual methanol in CD3OD 
was used as internal standard and the ratio between the areas of MDP protons (δ 
5.91) and the methyl group signals from residual methanol (δ 3.31) were used to 
draw the calibration curve (Paper V). The sesamin equivalent of metabolite was 
also analyzed by HPLC-DAD and the results were compared with those from 
NMR quantification. 
 
Pilot study on the effect of acidic condition on sesaminol triglucoside 
Defatted sesame flour was extracted by 80% ethanol and the extract was dried, 
dissolved in water (pH=0.8-1.5, HCl) and incubated at 37°C for 1, 3 and 20 hours. 
The samples were analyzed by LC-MS and HPLC-DAD and compared with a 
standard solution of sesaminol triglucoside subjected to similar treatment to 
investigate the effect of acidic incubation on sesaminol triglucoside in aqueous 
solution.  
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Interactions between sesamin and phytosterols with regard to 
lipid metabolism in rats 
Sprague Dawley rats were randomly assigned to 4 groups (n=6) with similar body 
weights. The experiment was performed in a 2×2 factorial design. Rats were fed 
diets containing sesamin (0 and 1.6 g/kg diet) and phytosterols (0.6 and 1.1 g/kg 
diet) for four weeks. At the end of the experiment, the rats were fasted for 12 
hours before being killed and their blood (plasma) and liver were collected and 
frozen. Plasma samples were analyzed for tocopherols and cholesterol and liver 
lipids were extracted and analyzed for tocopherols, cholesterol and fatty acid 
profile (Paper VI).  
 
 Results and discussion 
Characterization of new lignan glucosides (Papers I, II) 
Two new sesame lignan glucosides (Figure 7) were isolated and characterized in 
this thesis by NMR  (Table 2) and LC-MS (Table 3). 
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Figure 7. Sesaminol diglucoside and sesamolinol diglucoside isolated from sesame seeds. 
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Sesamolinol diglucoside 
(19) 
Sesaminol diglucoside 
           (14b) Table 2. 
1H-NMR  and 
13C-NMR spectral data of sesaminol diglucoside and sesamolinol 
diglucoside isolated from sesame seeds. 
Sesaminol Diglucoside  Sesamolinol Diglucoside  Position 
  δH  δC δH  δC
1 3.05  55.3  3.33  m  53.9 
2  5.21 d, J=4.7  82.6  5.65 s  108.3 
4  3.89 dd, J=4.2, 9.1 (a)   72.1  4.00 dd, J=1.1, 9.2 (a)  70.3 
4  4.22 dd, J=6.4, 9.1 (b)  -  4.15 dd, J=5.9, 9.2 (b)  - 
5  3.00 m  55.5  2.98 m  54.3 
6  4.66 d, J=5.4  86.6  4.46 d, J=7.0  88.5 
8  4.09 dd, J=4.4, 9.1 (a)  73.9  4.40 t
b
,  J=9.2, 9.2 (a)  71.7 
8  4.31 dd, J=7.3, 9.1 (b)  -  3.68 dd, J=5.1, 9.2 (b)  - 
1' -  125.6  -  154.8 
2'  -  150.5  6.73 d, J=2.5  103.8 
3' 6.93  s  99.5  -  151.8 
4' -  144.2  -  142.9 
5'  -  148.6  7.12 d J=8.8  119.4 
6'  6.85 s  105.7  6.62 dd, J=2.5, 8.8  109.5 
1" -  136.4  -  136.0 
2"  6.87  107.1  6.9 d, J= 1.7  107.2 
3" -  149.0  -  149.5 
4" -  148.6  -  148.7 
5"  6.77  108.8  6.79 d, J= 8.1  108.7 
6" 6.84  120.4  6.86  dd,  J= 1.7, 8.1  120.3 
-O-CH2-O-' 5.91  101.9  5.94  s  101.8 
-O-CH2-O-" 5.90  102.0  -  - 
-O-CH3 -  -  3.84  s  56,6 
G1 4.85
a
102.9  4.80 d, J= 7.3  103.3 
G2 3.46  74.86  3.47    74.8 
G3 3.68  77.0  3.43  77.4 
G4 3.44  71.1  3.40  71.1 
G5 3.45  77.9  3.58  77.6 
G6a  4.15 dd, J=1.9, 11.5   70.0  4.13 dd, J= 1.8, 11.7 (a)  69.3 
G6b  3.83 m   -  3.82 dd, J= 2.6, 11.7 (b)  - 
G1'  4.35 d, J=7.7  104.5  4.37 d, J= 7.7  104.2 
G2'  3.24 dd, J=8.1, 7.7  74.9  3.19  74.9 
G3' 3.36  77.7  3.30  77.6 
G4' 3.31  71.5  3.28  71.5 
G5' 3.21  77.7  3.20  77.7 
G6'a  3.85 m   62.7  3.87 m  (a)  62.7 
a 
Because of virtual higher order, the coupling constant could not be read.
b 
Resulting from 
the overlap of two doublets. 
G6'b  3.64 m   -  3.66 m  (b)  - 
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Sesaminol diglucoside (14b) (Figure 7)  
 H-1 (δ 3.05) appeared as a multiplet due to coupling with H-8a, H-8e and H-2. 
Similarly, H-5 (δ 3.00) appeared as a multiplet due to coupling with H-4a, H-4e 
and H-6. These results were confirmed by COSY. HMBC confirmed the coupling 
between H-2 (δ 5.21) and C-8 (δ 73.9) and between H-6 (δ 4.66) and C-4 (δ 72.1). 
HMBC also confirmed coupling between H-1 and C-1´ (δ 125.6), between H-2 
and C-5´ (δ 148.6), between H-5 and C-1˝ (δ 136.4) and between H-6 and C-6˝ (δ 
120.4) and C-2˝ (δ 107.1). 
1H NMR showed coupling between H-6˝ and H-2˝ 
(J=1.5 Hz). The position of C-4˝ (148.6 δ) was assigned from coupling with H-6˝ 
in HMBC. The aromatic carbons were assigned from coupling to corresponding 
hydrogen in HSQC. The glycosylation at C-2´ (δ 150.5) was confirmed by a cross 
peak with the anomeric proton (G1, δ 4.85) and a down-field shift in comparison 
with C-2˝ (δ 107.1). HMBC showed a cross peak between the anomeric proton 
(G1´,  δ 4.35) and C-G6 (δ 70.0) indicating a 1→6 bond between two sugars. 
Moreover, ROESY and NOESY spectra indicated a cross peak between the 
anomeric proton (G1′,  δ 4.35) and G6a (δ 3.83) and G6b (δ 4.15), which 
confirmed the result obtained by HMBC concerning the 1→6 bond between the 
two sugars. This sugar linkage (1→6) was different from that in other sesaminol 
diglucoside isomer (14a) isolated and characterized by Katsuzaki et al. (1994b), in 
which the sugar residue had 1→2 bond. The coupling constant for the anomeric 
protons G1´ (δ 4.88, J=7.70 Hz) confirmed the β-configuration of these proton 
(Katsuzaki  et al., 1994b), however for G1 (δ 4.85), because of virtual higher 
order, the coupling constant could not be read (Paper I). The structure of 
sesaminol triglucoside was assigned in the same way as for sesaminol diglucoside. 
Moreover, a peak, which was assigned as P3 on the HPLC-DAD chromatogram 
and co-eluted with sesaminol diglucoside at Rf=0.72-0.75 on TLC plates was 
collected using analytical HPLC and analyzed by LC-MS. It had similar ionization 
at positive mode with sesaminol diglucoside, however the pattern of ionization 
was different in negative mode Table 3. In addition, the UV spectrum of P3 was 
similar to sesaminol diglucoside Table 3. Therefore, P3 may be the sesaminol 
diglucoside (14a), which was previously isolated and characterized by Katsuzaki 
et al. (1994b). 
 
Sesamolinol diglucoside (19) (Figure 7) 
 H-1 (δ 3.3) appeared as a multiplet due to coupling with H-8a, H-8b, H-5 and H-
2, while H-5 (δ 2.98) appeared as a multiplet due to coupling with H-4a, H-4b, H-
1 and H-6, as confirmed by COSY. HMBC confirmed coupling between H-2 (δ 
5.65) and C-8 (δ 71.7), between H-6 (δ 4.46) and C-8 (δ 71.7), between H-4a (δ 
4.0) / H-8a (δ 4.40) and C-2 (δ 108.3), between H-8a (δ 4.40) and C-6 (δ 88.5), 
and between H-4a (δ 4.0) / H-4b (δ 4.15)  and C-6 (δ 88.5). HMBC also confirmed 
the coupling between H-6 (δ 4.46) and C-6˝ (δ 120.3) and C-2˝ (δ 107.2). 
1H-
NMR showed meta-coupling between H-6˝ and H-2˝ (J=1.7 Hz) and ortho-
coupling between H-6˝ and H-5˝ (J=8.1 Hz). The position of C-4˝ (δ 148.7) was 
assigned from the coupling with H-2˝ (δ 6.9), and the position of C-3˝ (δ 149.5) 
was assigned from the coupling with H-5˝ ( δ 6.79) by HMBC. The aromatic 
carbons were assigned from the coupling to the corresponding hydrogen by 
HSQC. The position of the methoxyl group of the aromatic ring was confirmed   37 
from a cross peak between its methoxy protons (δ 3.84) and C-3´ (δ 151.8). 
Glycosylation at C-4´ (δ 142.9) was shown by a cross peak with the anomeric 
proton (G1, δ 4.81) by HMBC. The NOESY spectrum indicated a cross peak 
between this anomeric proton (G1, δ 4.81) and H-5´ (δ 7.12), confirming the 
position of glycosylation on C-4´. An up-field shift in position C-4´ (δ 142.9) in 
comparison with position C-4˝ (δ 148.7) indicated the presence of two oxygen 
atoms in a para position around the benzene ring. Moreover, there were down-
field shifts in C-2 (δ 108.3) and C-1´ (δ 154.8) in comparison with C-6 (δ 88.5) 
and C-1˝ (δ 136.0). These results confirmed the presence of oxygen between the 
furofuran and benzene rings (Paper II). HMBC showed a cross peak between the 
anomeric proton (G1´, δ 4.37) and C-G6 (δ 69.3), indicating a 1→6 bond between 
the sugars. Moreover, the NOESY spectrum indicated a cross peak between the 
anomeric proton (G1′,  δ 4.37) and G6b (δ 4.13), confirming this 1→6 bond 
between the sugars (Paper II). This (1→6) sugar linkage is similar to that 
reported for sesaminol diglucoside discussed above.  
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Table 3. Characteristic studies of defatted sesame flour extract by TLC, HPLC-DAD and LC-MS. 
 
 
   
 
 
 
 
 
 
 
 
 
   a
Pre-coated silica gel 60 TLC plates developed by chloroform/methanol (1:1, v/v). 
b
The eluents used were: (A) 0.01 M phosphate buffer 
 (pH 2.8) containing  5% Acetonitrile and (B) Acetonitrile. The elution conditions were: 0-5 min (15% B), 30 min (30% B), 40-50 (70% B)  
and the flow rate was 1.0 mL/min. 
c
Electrospray ionization. The eluents used were: (A) 10 mM acetic acid (pH 3) and (B) Acetonitrile.  
The elution conditions were 0-5 min (20% B), 30-50 min (70% B) and the flow rate was 0.4 ml/min. At the interface, the drying gas 
 was set to 9 L/min, the nebulizer pressure was 30 psi, the drying gas temperature was 350 ºC and the scanning range was 300-1000 m/z.  
S3G: Sesaminol triglucoside, S2G: Sesaminol diglucoside. 
 
 
 
 
 
 
 
 
Compound 
  
 TLC
a 
  
    Rf
  
  HPLC
b
 tR (min) 
 
UV absorption
b
    (λ, nm) 
     
       LC-MS
c
  
   positive mode            
           
         LC-MS
c
      negative mode 
  Sesaminol   
Triglucoside 
 
0.36-0.41       19.0      238, 291  [S3G+Na]
+=879.2        [S3G-H]
-=855.2 
 Sesaminol  
Diglucoside 
 
0.65-0.72       25.6      238, 292  [S2G+Na]
+=717.1   [S2G+CH3COO]
- =753.2 
       P3  0.72-0.75        27.0      239, 293  [S2G+Na]
+=717.1         [S2G-H]
-=693.2 Development and validation of the analytical method for lignan 
glucosides (Paper I) 
The effects of ethanol percentage, extraction time, cake to solvent ratio and 
temperature on the extraction efficiency of lignan glucosides were investigated in 
this thesis, with more emphasis on sesaminol triglucoside. The recovery of 
sesaminol triglucoside depended on ethanol concentration, where 70% (9.9 mg/g 
of DSF) and 80% (10 mg/g of DSF) provided higher recovery of sesaminol 
triglucoside compared with 50% (7.6 mg/g of DSF), 60% (9.3 mg/g of DSF), and 
90% (3.3 mg/g of DSF) (p < 0.01). The recovery was increased over the time 
(from 15 h to 72 H) when DSF was extraction with 85% ethanol. However, the 
prolongation of the extraction time, from 15 h (9.8 mg/g of DSF) to 72 h (9.39 
mg/g of DSF), caused a 4.2% decrease in the yield of sesaminol triglucoside when 
DSF was extracted with 70% ethanol (p < 0.001), which can possibly be explained 
by degradation. To gain the mutual benefit of higher recovery and less 
degradation, a method was developed based on extraction with 85% ethanol for 5 
h followed by 70% ethanol for 10 h. This extraction method provided better yield 
(10.4 mg/g of DSF) in comparison with extraction with either 70% (9.9 mg/g of 
DSF) or 85% ethanol (5.9 mg/g of DSF) (p < 0.001). The recovery increased 
significantly (n = 5, p < 0.01,) when the DSF to solvent ratio decreased from 0.8 
g/10 mL (10.05 mg/g of DSF) to 0.25 g/10 mL (10.5 mg/g of DSF), but no 
significant difference in recovery was found between 0.25 g/10 mL (10.5 mg/g of 
DSF) and 0.5 g/10 mL (10.4 mg/g of DSF). Therefore, considering the small 
coefficient of variation (CV = 0.6%) when 0.5 g/10 mL was used, this was chosen 
as a proper ratio. To investigate the effect of extraction temperature on the 
extractability of sesaminol triglucoside, DSF was extracted at 20, 37, and 55°C. 
Statistical analysis revealed no difference between the different temperatures used 
and therefore, room temperature was chosen. Similar effects of ethanol 
percentage, extraction time and temperature were observed on the recovery of 
sesaminol diglucoside and sesamolinol diglucoside (Paper I).  
 
The effect of the solid matrix on the recovery of internal standard, naringenin, was 
investigated by spiking different amounts of DSF (0.25-0.8 g/10 mL) with 
different concentrations of internal standard (50-200 μg/mL). Analysis of variance 
indicated no significant effect of DSF matrix on the recovery of naringenin under 
the investigated range. The precision of the method was determined by analyzing 
sesaminol triglucoside in DSF in six different days. Each day, sesame cake was 
extracted and analyzed by HPLC using the method described. The intra-assay 
precision (within day variation) ranged from 0.6 to 2.8% with the average of 
1.6%, and the inter-assay precision (between days variation) was 2.8% (Paper I).  
 
Using sesaminol triglucoside standard, the detection limits of the method were 
determined as 10 mg/100 g of DSF for sesaminol triglucoside and 8 mg/100 g of 
DSF for sesaminol diglucoside and sesamolinol diglucoside using a signal-to-
noise ratio of 3. The concentration of lignan glucosides having a peak height 10 
times higher than noise was considered as the limit of quantification (40 mg/100 g 
of DSF for sesaminol triglucoside and 32 mg/100 g of DSF for sesaminol 
diglucoside and sesamolinol diglucoside). Linearity was confirmed between the 
  39 lowest and highest concentrations of sesaminol used in the standard curve (9 and 
435 μg/mL, respectively) (Paper I). In paper III the lignan glucosides analyzed 
in this thesis were reported as their aglycones equivalents, sesaminol and 
sesamolinol. The aglycones equivalent of detection limit and quantification limit 
were 2.2 and 8.8 μg/mL respectively for both sesaminol and sesamolinol. 
 
Validation of the analytical method for oil-soluble lignans  
Sesamin and sesamolin were analyzed by HPLC equipped with a fluorescence 
detector and a silica column as mentioned above. For sesamin and sesamolin, the 
oil-soluble lignans, the detection limits were determined 5 mg/100 g oil and 10 
mg/100g oil respectively using standard solutions and a signal-to-noise ratio of 3. 
The concentration of sesamin (15 mg/100g oil) and sesamolin (35 mg/100g oil) 
having peak height 10 times higher than noise were considered as the limit of 
quantification. Linearity was confirmed between quantification limit and highest 
concentration of sesamin and sesamolin used in standard solutions (75 µg/mL) 
(Paper III).  
 
Variation of lignans and lignan glucosides in sesame seeds and 
products 
The first group of samples was newly bred sesame seeds (n=65) from plants with 
different capsule types, which were grown in controlled condition. Sesaminol 
triglucoside, sesaminol diglucoside and sesamolinol diglucoside were analyzed in 
DSF and their aglycone equivalents in the seeds were calculated and presented in 
Table 4 (Papers I, II, III). The sesame oil-soluble lignans, sesamin and 
sesamolin, were also analyzed and their contents in seeds are presented in Table 4 
(Paper III). Total sesaminol, both in triglucoside and diglucoside form, ranged 
16-720 mg/100 g seeds (mean+SD 153±317 mg/100 g seed) and was higher than 
what Ryu et al. (1998) had previously reported in 25 cultivars. Sesamolinol, which 
was originally analyzed in glucoside form, ranged from undetectable to 124 
mg/100 g seed (31±53 mg/100 g seed). The analysis of variance indicated no 
significant difference between the content of lignan glucoside in black and white 
seeds (Papers I, II, III). Sesamin content ranged 7-712 mg/100g seeds (163±141 
mg/100g seed) and sesamolin content ranged 21- 297 mg/100g seed (101±58 
mg/100g seed). The analysis of data indicated a wider range of sesamin content 
than what was reported by Tashiro et al. (1990) but Hemalatha and Ghafoorunissa 
(2004) reported higher sesamin and sesamolin contents than what is reported in 
this thesis. The low sesamin and sesamolin contents found in this study were not 
observed by previous investigators (Kamal-Eldin & Appelqvist, 1994; Tashiro et 
al., 1990; Hemalatha & Ghafoorunissa, 2004; Yermanos et al., 1972; Fukuda et 
al.,1988a and Beroza et al., 1995). Statistical analysis revealed no significant 
difference between sesamin and sesamolin contents of white and black seeds 
(Paper III).  
 
The second group of sesame seeds and products were purchased from different 
markets (paper IV). The levels of lignans in 14 sesame seeds varied considerably. 
Sesamin (167-804 mg/100g seeds) was the major lignan followed by sesamolin 
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(48-279 mg/100g seeds) and sesaminol (32-298 mg/100g seeds) while sesamolinol 
was found in much lower concentrations (tr.–58 mg/100g seeds). The variations in 
the levels of sesamin, sesamolin and sesaminol and sesamolinol were within the 
wide range reported in previous publications (Kamal-Eldin & Appelqvist, 1994; 
Tashiro et al., 1990; Hemalatha & Ghafoorunissa, 2004; Yermanos et al., 1972; 
Fukuda et al.,1988a and Beroza et al., 1995) and what was already seen in this 
thesis for the first group of samples (Papers I, II, III). The levels of lignans in 4 
samples of dehulled seeds was also within the previously reported ranges 
suggesting that sesame lignans and lignan glucosides are not exclusively located in 
the hull. Dehulled sesame seeds are commercially interesting since they are used 
in food products including hamburger buns, tahini and halva. The level of lignans 
in crackers, biscuits and bread depends on the degree of incorporation of sesame 
seeds or oil. Virgin sesame oils and sesame oils extracted from roasted seeds 
contain comparable levels of sesamin and sesamolin, the native sesame seed 
lignans. 
 
The results obtained from the analysis of first and second groups of samples 
(Papers I, II, III, IV) suggest that sesame seeds may be as a rich source of lignans 
as flaxseed. Since sesame seeds are consumed as food to much larger extent than 
flaxseed, they and especially their oil might provide the richest sources of dietary 
lignans. It is, thus, important to include the intake of sesame seeds and products in 
studies aiming to estimate dietary intake of phytoestrogens. However, the wide 
variability in the types and levels of lignans in sesame seeds and oils poses a great 
challenge to their incorporation in databases. 
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Table 4. Variation in the contents of oil (%), sesamin, sesamolin , sesaminol and sesamolinol in 65 different sesame seed  
samples (group 1) (mg/100 g seed, fresh weight).        
 
 
 
 
 
 
258-1159 
 
 
 
 
 
 
 
 
 
 
 
 
 
  224-1148 
 
 
499-675 
433-862 
 
 
 
    Oil   Sesamin  Sesamolin  Sesaminol Sesamolinol  Total 
 
                                                              Plant with shattering capsules (n=29) 
Range 33-49  13-712 29-297  16-437  ND-110 
Mean     44    206  125    222      38     590 
                                                             
                                                           Plants with Semi-Shattering Capsules (n=7) 
Range 41-51  12-380 44-160  110-425  18-97 
Mean    46   146   119    269    52    587 
                                                                
                                                          Plants with Non-Dehiscent Capsules (n=29)  
Range 38-48  7-390  21-167  134-720  9-124 
Mean    44   124    73    424   68    688 
            
                                                                       All Sesame Seeds (n=65)           
Range 33-51  7-712  21-297  16-720  0-124 
Mean    44  163   101   153    31    581 Effect of shattering resistance on the lignan contents of sesame seeds 
(Paper III) 
The effect of capsule type on the lignan contents of sesame seeds was studied 
(Table 4). Seed samples from plants with semi-shattering (n=7) and non-dehiscent 
(n=29) capsules were analyzed for the first time in this thesis and their contents of 
lignans were compared with seeds from plans with shattering capsules (n=29). The 
analysis of variance showed that there was no difference between the sesamin 
content in seeds from plants with shattering and non-dehiscent capsules but the 
content of sesamolin was significantly higher in seeds from plants with shattering 
capsules (mean+SD 125±67 mg/100g) than in seeds from plants with non-
dehiscent capsules (73±37 mg/100g, p<0.001). Conversely, the contents of 
sesaminol and sesamolinol were higher in the seeds from plants with non-
dehiscent capsules (424±131 and 68±30 mg/100g seed, respectively) than their 
contents in the seeds from plants with shattering capsules (222±112 and 38±26 
mg/100g seed) respectively (p<0.001). The total lignan content (sum of sesamin, 
sesamolin, sesaminol and sesamolinol) was higher in seeds from plants with non-
dehiscent capsules (688±10 mg/100g seed) than the seeds from plants with 
shattering capsules (590±19 mg/100g seed, p<0.05) (Paper III). It was shown that 
lignan formation is developmentally regulated and depends on the stage of seed 
maturity. Therefore, the contents and ratio of lignans were changed by maturation 
(Jiao et al., 1998; Ono et al., 2006). This can possibly explain the differences 
observed in the contents of lignans in seeds from shattering and non-dehiscent 
capsules, which were harvested in different times. Higher sesamolin in seeds from 
shattering capsules, which was reported in this thesis, is in line with Jiao et al. 
(1998) that younger seeds had higher conversion of pinoresinol to sesamolin, 
while higher content of sesaminol observed in seeds from non-dehiscent capsules 
is in line with Ono et al. (2006) that more mature seeds contain higher sesaminol. 
Sesame seeds with shattering capsules are the most utilized today and are mainly 
grown in Asian and African countries. The plants are harvested by hand before 
drying of the capsules to prevent the loss of seeds on the field following capsule 
shattering. Non-dehiscent plants can be mechanically harvested on the field when 
the plant is dry providing economical advantages over the traditional, capsule-
shattering plants.  
 
Correlation of lignans and lignan glucosides 
The contents of sesamin and sesamolin in seeds were positively and significantly 
correlated (R
2= 0.69, p< 0.001) as were the contents of the glucosylated lignans, 
sesaminol and sesamolinol (R
2= 0.53, p< 0.001). The correlation between sesamin 
and sesamolin was stronger for black (R
2=0.77) than for the white seeds 
(R
2=0.66). The oil-soluble lignans, sesamin and sesamolin, correlated negatively 
with the glucosylated lignans, sesaminol and sesamolinol. It is likely that the 
positive correlation between sesamin and sesamolin is related to similar pathways 
in their biosynthesis and that the negative correlation with the glucosylated lignans 
is related to the activity of some enzyme(s) in the biosynthetic pathway. The few 
studies on the biosynthesis of sesamin and sesamolin do not provide information 
about pathways to the glucosylated lignans (Marchand et al., 1997; Kato et al., 
1998 and Jiao et al., 1998) (Paper III).  
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Human metabolism and urinary excretion of sesame oil lignans 
(paper V) 
Sesamin, the major sesame oil lignan, was shown to causes an increase in γ-
tocopherols in the plasma and liver and a reduction in liver cholesterol of rats 
contrary to secoisolariciresinol diglucoside, the major lignan glucoside in flaxseed 
(Kamal-Eldin  et al., 1995; Frank et al., 2004b). The differences between the 
physiological effects of sesamin and those of secoisolariciresinol diglucoside, 
while both of them are converted to mammalian lignans by intestinal microflora, 
indicate that sesamin exerts its effects possibly through its intact molecule or 
different metabolic products. In addition, the cleavage of methylenedioxyphenyls 
in sesamin to form catechol or methoxy catechol was already shown (Nakai et al., 
2003; Liu et al., 2006). Therefore, the aim of this study was to investigate the 
pattern of urinary metabolite(s) of sesame oil lignans in humans and to develop 
and validate a new quantitative NMR method to analyze the metabolite(s) in urine.  
 
Separation of the major sesamin metabolite 
Blank urine and the urine samples collected after sesamin intervention were 
incubated with deconjugating enzyme (β-glucuronidase/sulphatase) or acetate 
buffer without enzyme, extracted with chloroform and analyzed by HPLC. 
Comparision of the HPLC chromatograms of blank and treatment urine samples in 
the pilot study revealed that peaks eluting at retention time 35-42 min appeared 
only after deconjugation suggesting the presence as conjugated metabolites in 
urine. The chloroform extract of the deconjugated sesamin treatment urine 
possessed a peak (RT=37.5 min) with characteristic UV spectrum of lignans 
(λmax=234, 285 nm), which was not observed in the extract of deconjugated blank 
urine. This peak was collected from the HPLC effluent and characterized by NMR 
and LC-MS. 
 
 
Structural characterization of major sesamin metabolite in human urine 
The peak collected from HPLC as described above was analyzed by NMR and its 
1H and 
13C NMR spectra data are presented in Table 5. H-1 (δ 3.11) appeared as a 
multiplet due to coupling with H-8a, H-8b, H-5 and H-2 while H-5 (δ 3.09) 
appeared as a multiplet due to coupling with H-4a, H-4b, H-1 and H-6 as 
confirmed by COSY. HMBC showed the coupling between H-6˝ (δ 6.84) / H-2˝ (δ 
6.87) and C-6 (δ 87.1). 
1H NMR showed meta-coupling between H-6˝ and H-2˝ 
(J=1.5 Hz) and ortho-coupling between H-6˝ and H-5˝ (J=8.1 Hz). The position of 
C-4˝ (δ 148.7) was assigned from coupling with H-2˝ (δ 6.87) and H-6˝ (δ 6.84) 
and the positions of C-3˝ ( δ 148.7) and C-1˝ ( δ 136.2) were assigned from 
coupling with H-5˝ ( δ 6.77) in HMBC. Moreover, HMBC showed coupling 
between protons (δ 5.91) and C-4˝ (δ 148.7) confirming the presence of MDP 
group on this aromatic ring. On the other aromatic ring of the molecule, HMBC 
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1H 
NMR showed meta-coupling between H-6´ and H-2´ (J=1.8 Hz) and ortho-
coupling between H-6´ and H-5´ (J=8.1 Hz). The position of C-4´ (δ 145.7) was 
assigned from coupling with H-2´ (δ 6.8) and H-6´ (δ 6.69) and the positions of C-
3´ (δ 146.4) and C-1´ (δ 133.5) were assigned from coupling with H-5´ (δ 6.74) in 
HMBC. The presence of hydroxyl groups on this aromatic ring caused an up-field 
shift in positions C-3´ and C-4´ and a down-field shift in positions C-2´ and C-5´ 
in comparison with the corresponding positions on the other aromatic rings 
possessing MDP group. The aromatic carbons were assigned from coupling to 
corresponding hydrogen in HSQC. The molecular weight of isolated metabolite 
was further corroborated using LC-MS, where it had a [M-H]
- ion at m/z 341.2 
with electrospray ionization (ESI). Thus, the structure of the sesamin metabolite 
was established as (1R,2S,5R,6S)-6-(3,4-dihydroxyphenyl)-2-(3,4-
methylenedioxyphenyl)-3,7-dioxabicyclo-[3,3,0]octane by NMR and mass 
spectroscopy (Figure 8). 
 
 
Table 5. 
1H-NMR (600 MHz) and 
13C-NMR (199 MHz) spectral  
data of sesamin metabolite in human urine. 
 
 
Chemical shift  Position 
δH
 
       δC
  1 3.11  m 
 
55.1 
2  4.65 d, J=4.8  87.1 
  4 3.82  m 
 
72.4 
 4.20  m   
  5 3.09  m 
 
55.1 
6  4.7 d, J=5.1  87.1 
  8 3.83  m 
 
72.4 
 4.23  m   
  1' - 
 
133.5 
2'  6.8 d, J=1.8  114.2 
  3' - 
 
146.4 
4' - 
 
145.7 
5'  6.7 d,  J=8.1  116.2 
  6'  6.69 dd, J=1.8, 8.1  118.5 
  1" - 
 
136.2 
2"  6.87 d, 1.5  107.3 
  3" - 
 
148.7 
4" -  148.7 
5"  6.77 d, 8.1  108.7 
6"  6.84 dd, 8.1, 1.5  120.1 
-O-CH2-O- 5.91  s  101.8 
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Figure 8. Structure of (1) sesamin and (2) its urinary catechol metabolite characterized in 
this study.  
 
Quantitative NMR technique  
A NMR based method for the quantification of sesamin metabolite in the 
deconjugated urine extract using signal corresponding to MDP (δ 5.91) was 
developed in this thesis. The validation data was presented as follows: 
 
Experiments were performed to confirm that the peak corresponding to the MDP 
proton (δ 5.91) in 
1H-NMR spectra of the urine extracts belong to the sesame 
lignan metabolites. Comparison between 
1H-NMR spectra of the extract of blank 
urines and those of urines collected after sesamin intervention showed that the 
spectra contained MDP protons (δ 5.91) only after the intervention (Figure 9). 
Moreover, when the HPLC peak corresponding to the major sesamin metabolite 
was collected in a separate fraction (37-38 min) (Figure 9) this fraction contained 
protons with chemical shift at δ 5.91 in its NMR spectrum. The two other fractions 
collected between 0-37 min and between 38-70 min did not contain any signal 
with the chemical shift at δ 5.91. This provided evidence that protons on the MDP 
group of the metabolite (RT 37.5 min), which was characterized in this study, 
account for the signal at δ 5.91 in the 
1H-NMR spectrum of urine extracts. 
 
The detection limit of the NMR method for the metabolite was determined as 0.5 
μg/mL of urine using a signal-to-noise ratio of 3 and the limit of quantification 
was determined as 2 μg/mL of urine using a signal-to-noise ration of 10. Linearity 
was confirmed between the lowest and highest concentrations of sesamin used in 
calibration curve (0.1-0.4 µmol sesamin dissolved in 0.5 mL CD3OD). The 
sesamin equivalents of the metabolite in the urine extracts were determined using 
OH
OH
8 
 
1´ 
 
2´ 
  3´ 
 
4´ 
 
5´ 
 
6´ 
 
1 
 
2 
 
4 
5 
6 
1˝ 
6˝ 
5˝ 
4˝ 
3˝ 
2˝ 
(1)  (2) 
  46HPLC-DAD (285 nm) and the results were compared with the data obtained by 
the NMR method. The following correlation was obtained: Y=1.16X+4.06, 
R
2=0.91 where, Y and X were the concentrations (μg/mL of urine) of the 
metabolite as quantified by NMR and HPLC, respectively.  
 
 
 
          
 
Sesamin Urine 
-O-CH2-O-  Residual methanol 
2,6  1,5  2" 
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Figure 9. A) The comparison of 
1H-NMR spectra of the chloroform extracts of control 
urine and that of treatment urine after ingestion of sesamin. Signals are marked to the 
corresponding position on the metabolite molecule. B) Typical RP-HPLC chromatogram of 
chloroform extract of deconjugated human urine. 
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Urinary excretion of sesamin catechol metabolite 
Human volunteers (n=6) took muffins containing sesame-oil and the urinary 
excretion of sesamin, the major sesame oil lignan, in the form of its catechol 
metabolite, which was isolated and characterized in this thesis, was investigated. 
Table 6 presents the urinary excretion of sesamin catechol metabolite over four 
12-hour periods as quantified by the NMR technique explained vide supra. The 
majority of the sesamin metabolite was excreted during the first two 12-hour 
periods. For three subjects, small amount of the metabolite was detected in the 
third period and no metabolite was detected in urine samples collected over the 
fourth period. The excretion of the sesamin catechol metabolite in urine ranged 
22.2-38.6% (Mean±SD 29.3±5.6%) of ingested dose.  
 
No specific peak was detected in HLPC chromatogram or NMR spectra, which 
could be assigned to a sesamolin metabolite or other sesamin metabolites. 
Moreover, no sesamin or sesamolin was detected by HPLC-DAD in urine 
samples, which is in agreement with Coulman et al. (2005). Preliminary 
experiments showed that sesamolin is degraded under acidic condition of stomach. 
NMR data showed that the catechol metabolite possessing MDP signal (δ 5.91) in 
the H-NMR spectrum of urine extract does not contain any oxygen atom between 
its furofuran and benzene rings. This structural differentiation confirms the lack of 
contribution of sesamolin, the second major lignan consumed in this study, to the 
production of the catechol metabolite. 
 
Investigation of sesamin human metabolism in this thesis revealed that almost 
30% of dietary sesamin is excreted in the form of a major catechol metabolite. It 
was already shown that formation of intermediate complexes with cytochrome is 
more extensive with MDP compounds that contain electron donating substituents 
on their aromatic ring while CO production is favored by electron withdrawing 
substituents (Yu & Wilkinson, 1980). Therefore, it is plausible that after the 
formation of the first catechol group on the sesame molecule, the metabolite may 
bind to CYP 450 and the metabolism of sesamin does not continue to further 
oxidative demethylation of the second methylenedioxy group on the molecule 
after the formation of a catechol group in the first phenyl ring.  
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Table 6. Urinary excretion of sesamin catechol metabolite (mg) during a 4×12-hour-periods after a single oral dose of sesamin (180 mg).  
 
 
 
 
 
 
 
 
 
 
 
 
ND= Not Detected. The detection limit of the method for the metabolite was 0.5 μg/mL of urine using a signal-to-noise ratio of 3 and  
the limit of quantification was 2 μg/mL of urine using a signal-to-noise ratio of 10 on 
1H-NMR spectrum. 
 
 
 
 
 
Period (hour)  Subject 1  Subject 2  Subject 3  Subject 4  Subject 5  Subject 6 
                                                                             Excreted amount of the metabolite (mg) 
0-12  39.0 15.8 49.6 15.1 54.2 38.7 
12-24  12.5 50.3 1.1  25.2 ND  ND 
24-36  0.4   1.1 ND 3.0 ND ND 
36-48  ND ND ND ND ND ND 
38.7  Total    51.9 67.2 50.8 43.3 54.2 
                                                           Excreted amount of the metabolite (Percent of ingested dose) 
Total  29.8 38.6 29.2 24.8 31.1 22.2 Apart from 29.3% sesamin, which is excreted in the form of it catechol metabolite, 
the fate of the rest of the dose ingested is not clear. It was previously shown that 
only about 0.1% of sesamin is absorbed through the lymph (Hirose et al., 1991; 
Umeda-Sawada  et al., 1999) and that >40% of orally ingested sesamin was 
excreted as metabolites in the bile in rats (Nakai et al., 2003). It has also been 
shown that sesamin can be converted to enterolactone and enterodiol in humans 
(Penalvo et al., 2005; Coulman et al., 2005). The total recovery of enterolactone 
and enterodiol, after four weeks ingestion of sesame seeds, was reported as 14.9% 
of total seed lignans consumed by humans (Coulman et al., 2005). In this thesis, 
only small amounts of enterolactone were detected on the HPLC chromatograms 
after the single dose intervention with sesame oil. However, it was showed that the 
magnitude of plant lignans conversion to enterolactone and enterodiol is increased 
by longer intervention times (Smeds et al., 2004), which may account for the low 
conversion of sesame oil lignans to enterolactone in this study. Moreover, 
Coulman et al. (2005) and Penalvo et al. (2005) used sesame seeds instead of 
sesame oil, which was used in this thesis. 
 
Sesamin, like other lipophilic chemicals possessing MDP moiety, undergoes 
oxidative biotransformation and demethylation of its MDP group to form 
hydroxylated catechol metabolite (Murray, 2000). There is growing evidence that 
the epithelial cells (enterocytes) of human small intestine may provide the first site 
for cytochrome P450 (CYP)-catalyzed metabolism of orally ingested compounds 
(Scott Obach et al., 2001). It has also been proposed that high luminal 
concentration of ingested compounds may lead to a saturation of intestinal wall 
metabolism (Glaeser et al., 2004) and possibility change the absorption pattern. 
Moreover, initially, conjugation of phenolic compounds was thought to occur 
mainly in the liver, but phase II metabolism can also take place during uptake in 
the intestine (Jansen et al., 2005). Therefore, the investigation of the content of 
sesamin, sesamin catechol metabolite or conjugated sesamin metabolite in portal 
vein after ingestion of sesamin can reveal the form of absorption and also the 
contribution of intestinal metabolism and conjugation on final excreted sesamin 
catechol metabolite. Moreover, study on the possible efflux of sesamin or its 
metabolite from enterocytes back to lumen by p-glycoproteins may provide more 
data for better understanding the amount of sesamin absorbed. 
 
Effect of acidic condition on sesaminol triglucoside 
Incubation (37°C for 1, 3 and 20 hours) of DSF extract or sesaminol triglucoside 
standard in acidic condition (pH=0.8-1.5, HCl) to simulate the acidic condition of 
stomach, did not cause any hydrolysis of sesaminol triglucoside as no peak 
corresponding to its sesaminol aglycone or other sesaminol glucosides were 
detected and incubation of sesaminol triglucoside standard did not generate any 
peak with ions corresponding to other lignan glucosides in its spectrum. However, 
the acidic incubation generated three new peaks beside sesaminol triglucoside, 
which possessed similar UV spectra and major ions to sesaminol triglucoside in 
their spectra in both positive [S3G+Na]
+=879.2 and negative  [S3G-H]
-=855.2 ESI 
modes. Stereochemical changes of the bonds in position 2 and 6 of furofuran ring 
can possibility explain the three new chromatographic peaks since four different 
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This reaction can possibly be stimulated in aqueous solution since sesaminol 
triglucoside is a water soluble compound. 
 
Interactions between sesamin and phytosterols with regard to 
lipid metabolism (Paper VI) 
Sesamin (Hirose et al., 1991) and phytosterols (de Jong et al., 2003) are known to 
inhibit the incorporation of cholesterol into mixed micelles and, as a result, lower 
its absorption. Since sesamin and phytosterols competitively inhibit the absorption 
of other fat-soluble nutrients, it was investigated in a rat model if they may affect 
each other’s physiological effects possibility by reducing their respective 
bioavailabilities. The phytosterols in the diet did not affect γ-tocopherol 
concentrations in plasma or liver. Sesamin, on the other hand, elevated γ-
tocopherol in both tissues (p<0.001) in agreement with previously published data 
(Kamal-Eldin et al., 1995, 2000). However the magnitude of this effect was 
reduced when the content of phytosterols in diet was increased (p<0.01). 
 
Both sesamin and phytosterols individually decreased liver cholesterol to a small 
extent, albeit not significantly. However, when sesamin and phytosterols (1.1 g/kg 
diet) were fed together, a significant interaction was observed that nullified the 
individual cholesterol-lowering effects of the compounds (p<0.05). Similarly, 
sesamin intake increased the percentage of arachidonic acid (20:4n-6) and 
dihomo-γ-linolenic acid (20:3n-6) in liver lipids (p<0.05) in agreement with 
Mizukuchi et al. (2003). Again, the effect of sesamin on dihomo-γ-linolenic acid 
was abolished when the content of phytosterols was increased in the diet. Sesamin 
exerts it effects on arachidonic acid content both through reduction of its 
biosynthesis by inhibiting Δ5-desaturase (Shimizu et al., 1991; Chavali & Forse, 
1999) and possible reduction of its ω-hydroxylation by inhibiting CYP4F2 
(Powell  et al., 1998). Therefore, the interpretation of the effect of sesamin on 
arachidonic acid content is more complex being dependant on the inhibition of the 
activities of Δ5-desaturase, CYP4F2 and β-oxidation by sesamin. 
 
The findings in this thesis suggest that dietary phytosterols may reduce the 
bioavailability and, hence, the biopotency of sesamin or its metabolites. 
Consumption of phytosterols was already shown to reduce the bioavailability of β-
carotene and α-tocopherol (Richelle et al., 2004). The facts that both sesamin and 
phytosterols are constituents of vegetable oils and that sesamin inhibit the 
absorption of cholesterol make it possible that they compete for incorporation into 
mixed micelles, which is a necessary step for absorption.  In addition, phytosterols 
are ligands for liver X receptors (LXRs), which can induce the expression of some 
p-glycoproteins (de Jong et al., 2003) that may cause efflux of sesamin from 
enterocytes back to the lumen and reduce its absorption. It was recently shown that 
administration of sesamin and stanol can reduce the formation of enterodiol in 
LDL receptor-deficient mice (Penalvo et al., 2006). Moreover, it was shown that 
almost 40% of sesamin is recovered in the form of its metabolites in the bile 
(Nakai et al., 2003) showing the possible importance of first pass contribution 
(metabolism in intestinal cells and liver) in the metabolism of sesamin, which 
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Therefore, any reduction in sesamin absorption may reduce the metabolites in the 
first pass, which may contribute to the reduction of final metabolic products 
(enterolactone and enterodiol) as was observed by Penalvo et al. (2006).  
 
It was found that 0.1% of ingested sesamin is absorbed through the lymph in rats 
(Hirose et al., 1991; Umeda-Sawada et al., 1999).
 However, we have shown in this 
thesis that almost 30% of dietary sesamin is excreted in the form of a catechol 
metabolite by humans (Paper V). Investigation of the pharmacokinetics of this 
metabolite and its urinary exertion in the presence (single dose or long-term 
intervention) or absence of phytosterols can provide data for better understanding 
of possible interaction of sesamin and phytosterols during absorption.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  52Summary and conclusions 
The finding of this thesis can be summarized as follow: 
 
• Two new lignan glucosides, sesaminol diglucoside and sesamolinol diglucoside, 
were isolated from sesame seeds and characterized. 
 
• Lignan glucosides were analyzed by a validated method. It was found that 
sesaminol triglucoside is the major lignan glucoside in sesame seeds and that 
almost 32% of total lignans in sesame seeds are in glucosylated form.  
 
• Data on variation of lignans and lignan glucosides in different sesame seeds and 
products indicated that sesame seed is as a rich source of lignans as flaxseed. 
However, the variations in the contents of lignan in sesame seeds, oil and products 
are high, which should be considered for their possible incorporation in functional 
foods. 
 
• Sesame seeds from plant with non-dehiscent capsules contained higher amounts 
of sesaminol and sesamolinol and lower amounts of sesamin and sesamolin than 
sesame seeds from plants with shattering capsules.  
 
• The contents of oil-soluble lignans in sesame seeds were negatively correlated to 
lignan glucosides. There were positive correlations between oil-soluble sesamin 
and sesamolin and between glucosylated sesaminol and sesamolinol. 
 
• A new NMR technique was developed to quantify the urinary metabolite of 
sesamin in humans based on using methylenedioxyphenyl signal (δ 5.91) in 
1H-
NMR spectra of deconjugated urine extracts to measure the metabolite content. 
 
• Almost 30% of a single oral dose of sesamin (180 mg) is excreted in the form of 
a major catechol metabolite in human urine and the majority of excretion occurred 
in the first 24-hour period.  
 
• Simultaneous consumption of phytosterols and sesamin reduced the biopotency 
of sesamin in its lipid modulating effects in rats.   
 
 
 
 
 
 
 
 
  53 Future research 
Little is know about the biosynthesis of sesame lignan glucosides and their role in 
the plant, which is needed to be elucidated.  
 
It was shown in this thesis that 30% of sesamin is excreted in the form of a 
catechol metabolite. However, little is know about sesamin absorption. Therefore 
the analysis of sesamin or its major metabolite(s) in portal vein can reveal the 
major form of absorption of sesamin and the possible contribution of intestinal 
metabolism in sesamin absorption. It was already know that just 0.1% of sesamin 
is absorbed through the lymph in rats. Nevertheless, all the pharmacokinetic data 
available is for sesamin and therefore, study on the pharmacokinetics of the 
sesamin catechol metabolite is necessary.   
 
Comparison between pharmacokinetic data of sesamin or its metabolite in 
presence or absence of phytosterols can also be used for interpretation of the 
interaction between sesamin and phytosterols observed in this thesis.  
 
The possible contribution of p-glycoproteins and cytochromes in absorption of 
sesamin and the possible interaction of sesamin or other sesame seed lignans with 
nuclear receptors especially pregnane X receptor (PXR), liver X receptor (LXR) 
and constitutive androstane receptor (CAR) can provide a better insight of the 
effects of sesame lignans on human metabolism.  
 
In this thesis, major sesame lignan glucosides were isolated and quantified, 
however little is know about their metabolism, absorption and possible 
contribution in the production of mammalian lignans. Therefore, studies on the 
metabolism and absorption of lignan glucosides are necessary. 
 
Negative correlations between the consumption of phytoestrogens and breast and 
prostate cancer have been shown. However, little is know about the contribution 
of sesame seed lignans to phytoesterogen intake, which is important for studies 
aiming at establishing such diet/health relations.   
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